Pfizer Consumer Healthcare announced that it will remove claims related to breast and colon health on advertising and labeling for certain Centrum multivitamin supplements, as part of an agreement with the Center for Science in the Public Interest (CSPI).

Specifically, the company will drop “breast health” claims from Centrum Ultra Women’s and Centrum Silver Women’s multivitamin supplements, and “colon health” claims from Centrum Ultra Men’s and Centrum Silver Ultra Men’s supplements. This is to remove any misleading implications of disease prevention claims. For products that bear a claim regarding “heart health,” Pfizer will add clarifying language that the products are “not a replacement for cholesterol-lowering drugs.” In addition, for products that bear an energy claim, Pfizer will clarify that the products do not directly provide an energy boost, but rather help support metabolic function.

The changes negotiated with CSPI will be made on Pfizer web sites and advertising within 30 days of today, and changes on product labels will be implemented over the next six months as supplies of packaging are depleted.

For more information call (877) CENTRUM or visit